US eye drop manufacturer K.C. Pharmaceut
The USFDA Warning letter to K. C. Pharmaceuticals issued in August 2023, following inspection at
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
